Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Sunday
May 08
10:30 - 11:30
Room D5
Radiomics & modelling
Claudio Fiorino, Italy;
Marta Bogowicz, The Netherlands
Proffered Papers
Physics
10:30 - 10:40
RBE models of brainstem toxicity from proton therapy of paediatric ependymoma
Andreas Havsgård Handeland, Norway
OC-0455

Abstract

RBE models of brainstem toxicity from proton therapy of paediatric ependymoma
Authors:

Andreas Havsgård Handeland1, Daniel J. Indelicato2, Lars Fredrik Fjæra3, Kristian S. Ytre-Hauge3, Helge Egil S. Pettersen1, Yasmin Lassen-Ramshad4, Ludvig P. Muren5, Camilla H. Stokkevåg1,3

1Haukeland University Hospital, Department of Oncology and Medical Physics, Bergen, Norway; 2University of Florida, Department of Radiation Oncology, Jacksonville, USA; 3University of Bergen, Department of Physics and Technology, Bergen, Norway; 4Aarhus University Hospital, Danish Centre for Particle Therapy, Aarhus, Denmark; 5Aarhus University , Department of Medical Physics, Aarhus, Denmark

Show Affiliations
Purpose or Objective

Brainstem necrosis is a rare, yet severe side-effect of paediatric radiotherapy. The cause is likely multifactorial, with one possible contributor being uncertainty in the relative biological effectiveness (RBE) of protons. A constant RBE=1.1 is assumed clinically, but the RBE is known to vary with linear energy transfer (LET), as well as radiosensitivity of tissue and dose fractionation. Variable RBE-based predictive models are therefore needed for treatment plan optimisation. The aim of this study was thus to investigate the effect of LET and variable RBE in normal tissue complication probability (NTCP) modelling of brainstem necrosis following paediatric ependymoma.

Material and Methods

CT and dose data from a case-control cohort (n=28, 1:3 case-control ratio) of symptomatic brainstem necrosis was selected from 954 paediatric patients having undergone passive scattered proton therapy. The matching was based on gender, diagnosis, treatment-related factors and RBE1.1 dose data. The FLUKA Monte Carlo code was used to calculate LET and variable RBE (using Rørvik, McNamara and dose-averaged LET (LETd)-weighted dose). LETd was studied both for full structure volumes, as well as restricted to volumes with high dose thresholds. Logistic regression (LR) was used to fit NTCP models. Dose, LETd and volumes were included in the models based on odds-ratios (ORs) from univariate conditional LR and Spearman rank coefficients. Machine learning algorithms were fitted for comparison. Model evaluation included leave-one-out cross validation (LOOCV), area under receiver operating characteristic curve (AUROC) and precision-recall curve (AUPRC), and Brier score.  

Results

Variable RBE led to increased RBE-weighted dose (figure 1). Most structures presented with 0.5–1.5keV/µm higher average L50%, L10% (the LETd to the respective volume percentages) and Lmax (L0.1cc) in cases compared to controls. These differences translated to ORs in the range 1.5–7 for full volumes and approaching 30 including dose thresholds. The difference in D50%, D10% and Dmax (D0.1cc) across cases and controls also increased from constant to variable RBE, with 0.5–1.5 Gy(RBE) higher dose to cases with the McNamara model. The selected NTCP models were a univariate and bivariate LR models achieving high performance scores (table 1). The univariate model considered brainstem L10% (D>54 Gy(RBE) from RBE1.1), while the bivariate model also included the anterior pons volume which was negatively correlated with toxicity. The LR models had comparable performance measures to most machine learning algorithms, excluding the bivariate neural network with similar LOOCV accuracy only.


Conclusion

The most pronounced risk was associated with increased LETd in volumes above 54Gy(RBE). The univariate model incorporating brainstem L10% was the preferred model based on simplicity and solid performance. The bivariate model, while more complex, is strengthened by the inclusion of a parameter independent of dosimetry.